Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc.
1:16-cv-00540
Overview
Parties
Defendant
Sanofi-Aventis U.S. LLC Operating Company
Represented By
10 Attorneys ListedRatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
RatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
Plaintiff
Genzyme Corporation NPE (Individual / Inventor)
Represented By
10 Attorneys ListedRatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
RatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
Counter Claimant
Zydus Pharmaceuticals (USA) Inc. Operating Company
Represented By
5 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 11 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7897590
Methods to mobilize progenitor/stem cells
|
Filed: 2007-08-20
Issued: 2011-03-01
|
Expired (Term Ended)
Expires: 2024-11-16
|
|
|
US6987102
Methods to mobilize progenitor/stem cells
|
Filed: 2002-07-30
Issued: 2006-01-17
|
Expired (Term Ended)
+357d PTA
Expires: 2023-07-22
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred โ Patent expired. Under 35 U.S.C. ยง 283, injunctive relief is barred.
Standard Statutory Term โ No obviousness-type double patenting noted.
Under 35 U.S.C. ยง 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
5
Dispositive
0
Granted
0
Denied
0
Pending / Review
5
Motions by Category
Key Dispositive Motions & Rulings